Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good to see - sometimes difficult to get the right timing
What's moving it, any news?
.70 after hours. Dollar soon
Looks good so far - why are you so sure about it?
Bottom was Friday at .54. It will hold.
$aiki $0.58 v -0.0096 (-1.63%)
Volume: 2,407,867 @09/04/20 7:59:28 PM EDT
Alkido Pharma Inc (AIKI)
0.58 ? -0.0096 (-1.63%)
Volume: 2,407,867 @09/04/20 7:59:28 PM EDT
Bid Ask Day's Range
0.57 0.78 0.5301 - 0.6347
AIKI Detailed Quote
She is waking up.
Thx that’s what I thought too
Nssrr5 - too many compliance for reading that now. What could apply to Aiki?
Which rule is that?
I thought it might be 1 USD at least.
Thx
This to stay complied with NASDAQ at a minimum
Perfect time to buy
There were weeks with millions of USD volume...silence
I started to nibble this morning - good luck.
watching to see if this one bounces or continues to slide down.
Your very welcome...
Nice looking chart. Thanks!
AIKI...Added 72s...accumulating on this Oversold Chart below the 50ma...will add accordingly...
Chart...http://schrts.co/BJIuHBdF
CANT REMEMBER..I just know ITS 21.6MILLY READ THE FILINGS LOL
Avgr bro lol
How is that company called?
at what price is this offering?
Damn glad I didn’t get in.
AIKI...80...in the P/M...Following the S1...Scaling in here in case the Earnings report is solid...Will add accordingly following the Earning Report on Wednesday...
https://www.otcmarkets.com/filing/html?id=14340728&guid=cBl6UqE6ed8dq8h
it's only just begun 21milly share offering
I hope you bought AVG$ today....You might get a decent price before it runs...
Yes I did, starkd.
I hope you listened 21.6 milly share offering....
Enjoy ride back up the selling has pretty muted dried up
Well damn there they are.
Waiting for .70s here
Getting now, looks like way over sold
Getting close to taking a position here.
I was hopping they'd come up with some help with covid cure, with all the patents they've been releasing by HOTH and and AIKI.
Alkido Pharma Inc (AIKI)
0.875 ? -0.0022 (-0.25%)
Volume: 1,281,393 @08/14/20 7:59:40 PM EDT
Bid Ask Day's Range
0.8602 0.9 0.88 - 0.919
AIKI Detailed Quote
Next Earnings scheduled date is August 19...so will see what happens there...
Looking for an entry myself. I think this sees .70 range again soon.
AIKI...886...Scaling back in on the Bullish Homing Pigeon Reversal Pattern to the Upside...Bollie Squeeze is Diverging as AIKI pierced the lower Bollie to the Downside...setting up a strong bouncer possibility here following the 2 Gap Down candles on the Oversold Williams...imo...we shall see...
As of August 5, 2020, there were 34,920,219 shares of the Company’s common stock issued and outstanding.
georgie18...08/11/2020
AIKI...$1.15...all out for now from my .70 range shares...on the $1.33 move ...Do not like the candle and too much risk to leave all that profit on the table...Watching for another entry as the Bollies are Squeezing...
Chart...http://schrts.co/ZKdsXsax
Even more tempting...
Followers
|
156
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8287
|
Created
|
12/30/04
|
Type
|
Free
|
Moderators |
Kucera Paper Lipid Nucleoside Conjugates for the Treatment of Cancer
Kucers & Pardee Paper Improving Nucleoside Analogs via Lipid Conjugation
The Phospholipid Gemcitabine Conjugate, KPC34, is a Novel Treatment for Leukemia
Short-term Toxicity Study of DHA-dFdC
AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices,
but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual
and institutional investor includes stock price and history, upcoming events and presentations and financial documents.
AIkido Pharma Inc. is traded on the Nasdaq under the ticker symbol AIKI.
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.
The Spherix platform contains patented technology from leading universities and researchers and we seek to develop
our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University.
Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models.
The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care.
In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
https://ir.aikidopharma.com/stock-information/
$AIKI Spherix Incorporated, a biotechnology company,focuses on developing small-molecule anti-cancer therapeutics.
Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
The company's platform consists of patented technology from leading universities and researchers and in the process of developing an
innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at
Austin and Wake Forest University.
It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic
markers in people that indicate an increased risk of developing pancreatic cancer.
Spherix Incorporated was founded in 1967 and is based in New York, New York.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |